Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PRLD - Prelude Therapeutics Incorporated
136 M
LAST VALUE
-9.05%
2 YEAR CAGR
50.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR